Kalra Balkrishan 4
4 · Genpact LTD · Filed Sep 15, 2025
Insider Transaction Report
Form 4
Kalra Balkrishan
DirectorPresident and CEO
Transactions
- Sale
Common Shares
2025-09-11$43.35/sh−40,000$1,734,000→ 295,246 total - Sale
Common Shares
2025-09-11$43.39/sh−15,000$650,850→ 295,246 total - Exercise/Conversion
Common Shares
2025-09-11$27.65/sh+40,000$1,106,000→ 335,246 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-09-11−40,000→ 2,800 totalExercise: $27.65Exp: 2026-03-31→ Common Shares (40,000 underlying)
Footnotes (3)
- [F1]The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $43.39 to $43.40. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F2]The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $43.29 to $43.42. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The option vested 50% on January 10, 2019 and the remainder on January 10, 2021.